| Authors: |
Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Maclachlan K; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic., Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA., Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA., Mai E; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. |
